{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:18:40Z","timestamp":1791357520183,"version":"4.3.1"},"reference-count":32,"publisher":"American Medical Association (AMA)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2019.3209","type":"journal-article","created":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T15:46:08Z","timestamp":1556898368000},"page":"e193209","source":"Crossref","is-referenced-by-count":64,"title":["Naloxone Prescriptions Among Commercially Insured Individuals at High Risk of Opioid Overdose"],"prefix":"10.1001","volume":"2","author":[{"given":"Sarah","family":"Follman","sequence":"first","affiliation":[{"name":"University of Chicago Pritzker School of Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vineet M.","family":"Arora","sequence":"additional","affiliation":[{"name":"Section of General Internal Medicine, University of Chicago Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Lyttle","sequence":"additional","affiliation":[{"name":"Center for Health and the Social Sciences, University of Chicago Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. Quincy","family":"Moore","sequence":"additional","affiliation":[{"name":"Section of Emergency Medicine, University of Chicago Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai T.","family":"Pho","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases and Global Health, University of Chicago Medicine, Chicago, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2019,5,3]]},"reference":[{"issue":"12","key":"zoi190140r1","doi-asserted-by":"publisher","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants\u2014United States, 2015-2016.","volume":"67","author":"Seth","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi190140r2","doi-asserted-by":"publisher","first-page":"79","DOI":"10.2147\/SAR","article-title":"Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review.","volume":"8","author":"Lewis","year":"2017","journal-title":"Subst Abuse Rehabil"},{"issue":"1","key":"zoi190140r3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","article-title":"Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal.","volume":"158","author":"Coffin","year":"2013","journal-title":"Ann Intern Med"},{"issue":"1","key":"zoi190140r4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12954-017-0178-6","article-title":"Harm reduction in the USA: the research perspective and an archive to David Purchase.","volume":"14","author":"Des Jarlais","year":"2017","journal-title":"Harm Reduct J"},{"issue":"48","key":"zoi190140r5","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","article-title":"Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2014United States, 2013.","volume":"64","author":"Des Jarlais","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"zoi190140r8","doi-asserted-by":"publisher","first-page":"2073","DOI":"10.1001\/jama.2018.4867","article-title":"Increasing naloxone awareness and use: the role of health care practitioners.","volume":"319","author":"Adams","year":"2018","journal-title":"JAMA"},{"issue":"2S","key":"zoi190140r11","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1016\/j.japh.2016.11.007","article-title":"State legal innovations to encourage naloxone dispensing.","volume":"57","author":"Davis","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"9","key":"zoi190140r12","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1093\/pm\/pnx140","article-title":"Attitudes, beliefs, practices, and concerns among clinicians prescribing opioids in a large academic institution.","volume":"19","author":"Ebbert","year":"2018","journal-title":"Pain Med"},{"issue":"1","key":"zoi190140r13","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1080\/08897077.2017.1356787","article-title":"Awareness of state legislation on naloxone accessibility associated with willingness to prescribe naloxone.","volume":"39","author":"Okoro","year":"2018","journal-title":"Subst Abus"},{"issue":"2","key":"zoi190140r15","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/08897077.2015.1010032","article-title":"A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice.","volume":"36","author":"Mueller","year":"2015","journal-title":"Subst Abus"},{"issue":"3","key":"zoi190140r16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.drugalcdep.2010.10.021","article-title":"Rates and correlates of mortality amongst heroin users: findings from the Australian Treatment Outcome Study (ATOS), 2001-2009.","volume":"115","author":"Darke","year":"2011","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"zoi190140r17","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1197\/j.aem.2007.04.005","article-title":"Identifying injection drug users at risk of nonfatal overdose.","volume":"14","author":"Coffin","year":"2007","journal-title":"Acad Emerg Med"},{"issue":"4","key":"zoi190140r18","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1093\/aje\/kwr318","article-title":"Mortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study.","volume":"175","author":"Evans","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"4","key":"zoi190140r19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1465-3362.2009.00057.x","article-title":"Overdose deaths following previous non-fatal heroin overdose: record linkage of ambulance attendance and death registry data.","volume":"28","author":"Stoov\u00e9","year":"2009","journal-title":"Drug Alcohol Rev"},{"issue":"2-3","key":"zoi190140r20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.drugalcdep.2006.12.019","article-title":"Overdose after detoxification: a prospective study.","volume":"89","author":"Wines","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"zoi190140r21","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1080\/08897077.2016.1142921","article-title":"Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings.","volume":"37","author":"Wilson","year":"2016","journal-title":"Subst Abus"},{"issue":"31","key":"zoi190140r22","doi-asserted-by":"publisher","first-page":"845","DOI":"10.15585\/mmwr.mm6731a1","article-title":"Opioid use disorder documented at delivery hospitalization\u2014United States, 1999-2014.","volume":"67","author":"Haight","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"31","key":"zoi190140r23","doi-asserted-by":"publisher","first-page":"799","DOI":"10.15585\/mmwr.mm6531a2","article-title":"Incidence of neonatal abstinence syndrome\u201428 states, 1999-2013.","volume":"65","author":"Ko","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"4","key":"zoi190140r26","doi-asserted-by":"publisher","first-page":"207","DOI":"10.5055\/jom.2017.0389","article-title":"Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse.","volume":"13","author":"Wollschlaeger","year":"2017","journal-title":"J Opioid Manag"},{"key":"zoi190140r28","article-title":"Beliefs associated with pharmacy-based naloxone: a qualitative study of pharmacy-based naloxone purchasers and people at risk for opioid overdose","author":"Donovan","journal-title":"J Urban Health"},{"key":"zoi190140r29","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.japh.2017.01.013","article-title":"Perpetuating stigma or reducing risk: perspectives from naloxone consumers and pharmacists on pharmacy-based naloxone in 2 states.","volume":"57","author":"Green","year":"2017","journal-title":"J Am Pharm Assoc (2003)"},{"issue":"23","key":"zoi190140r30","first-page":"631","article-title":"Opioid overdose prevention programs providing naloxone to laypersons\u2014United States, 2014.","volume":"64","author":"Wheeler","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"zoi190140r31","doi-asserted-by":"publisher","first-page":"f174","DOI":"10.1136\/bmj.f174","article-title":"Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysis.","volume":"346","author":"Walley","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"zoi190140r32","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3109\/15360288.2012.738288","article-title":"The use of prescription monitoring programs to reduce opioid diversion and improve patient safety.","volume":"27","author":"Morgan","year":"2013","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"zoi190140r6","unstructured":"MurthyVH. Opioid epidemic: we all have a role in turning the tide. https:\/\/obamawhitehouse.archives.gov\/blog\/2016\/10\/05\/opioid-epidemic-we-all-have-role-turning-tide. Accessed March 20, 2019."},{"key":"zoi190140r7","unstructured":"US Department of Health and Human Services. Surgeon General\u2019s advisory on naloxone and opioid overdose. https:\/\/www.surgeongeneral.gov\/priorities\/opioid-overdose-prevention\/naloxone-advisory.html. Accessed March 20, 2019."},{"key":"zoi190140r9","unstructured":"Centers for Disease Control and Prevention. CDC guideline for prescribing opioids for chronic pain. https:\/\/www.cdc.gov\/drugoverdose\/pdf\/guidelines_at-a-glance-a.pdf. Accessed March 20, 2019."},{"key":"zoi190140r10","unstructured":"Federation of State Medical Boards. Guidelines for the chronic use of opioid analgesics. https:\/\/www.fsmb.org\/siteassets\/advocacy\/policies\/opioid_guidelines_as_adopted_april-2017_final.pdf. Accessed March 20, 2019."},{"key":"zoi190140r14","unstructured":"MooreBJ, BarrettML. Case study: exploring how opioid-related diagnosis codes translate from ICD-9-CM to ICD-10-CM. https:\/\/www.hcup-us.ahrq.gov\/datainnovations\/ICD-10CaseStudyonOpioid-RelatedIPStays042417.pdf. Accessed March 20, 2019."},{"key":"zoi190140r24","unstructured":"National Vital Statistics System. Provisional drug overdose death counts. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm. Accessed March 20, 2019."},{"key":"zoi190140r25","unstructured":"National Center for Health Statistics. Ambulatory care use and physician office visits. https:\/\/www.cdc.gov\/nchs\/fastats\/physician-visits.htm. Accessed March 20, 2019."},{"key":"zoi190140r27","unstructured":"AhrnsbrakR, BoseJ, HeddenSL, LipariRN, Park-LeeE; Substance Abuse and Mental Health Services Administration. Key substance use and mental health indicators in the United States: results from the 2016 National Survey on Drug Use and Health. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/NSDUH-FFR1-2016\/NSDUH-FFR1-2016.htm. Accessed March 20, 2019."}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/\/jamanetworkopen\/article-pdf\/2\/5\/e193209\/17552997\/follman_2019_oi_190140.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,3]],"date-time":"2019-05-03T15:46:12Z","timestamp":1556898372000},"score":1,"resource":{"primary":{"URL":"http:\/\/jamanetworkopen.jamanetwork.com\/article.aspx?doi=10.1001\/jamanetworkopen.2019.3209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,3]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.3209","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,3]]}}}